Why the study?
What are the national trends in the pharmacological treatment of atrial fibrillation in the US between 1980 and 1996?
Population
1555 visits by patients with atrial fibrillation to randomly selected office-based US physicians included in…
Design
Cross-sectional
Authors
Loading...
Historical AF treatment shifts may reflect evolving practices; leaves open whether patterns persist or affect outcomes in contemporary cohorts.
What are the national trends in the pharmacological treatment of atrial fibrillation in the US between 1980 and 1996?
This historical analysis shows that from 1980 to 1996, digoxin remained the dominant rate control medication for AF, while the use of sinus rhythm agents fluctuated, declining in the 1980s before rising again in the mid-1990s.
Stafford et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: